Several high profile companies are working on new experimental vaccines. Drug giant Johnson & Johnson is the latest to announce a promising vaccine candidate, saying on Monday that it plans human testing by September with the hopes of having more than one billion doses of a vaccine available for emergency use by early 2021.J&J said it was partnering with the Biomedical Advanced Research and Development Authority of the U.S.
Gupta stunned by Trump-Fauci difference at briefing 02:09Shares of Moderna, Novavax, Inovio and BioNTech have all soared this year, even as the broader market has plunged due to worries about the impact of the coronavirus on the global economy. Read MoreBut making and testing new vaccines may not wind up being the fastest way to treat Covid-19, says Sergey Young, founder of the Longevity Vision Fund -- a firm that invests primarily in smaller private biotechs.
Sounds good. But tell us where these companies are located. And where their drugs will be manufactured. Or better yet, I'll tell everyone........In CHINA baby....Same place the disease came from. Go ahead, swallow that cure.